Skip to main content
. 2004 Jul 27;91(5):873–878. doi: 10.1038/sj.bjc.6602074

Figure 2.

Figure 2

Distribution of patients with elevated levels of serum CYFRA 21-1, CEA, and CA 15-3 in primary and recurrent breast cancer. The number in each area is the number of patients with elevated levels of tumour markers.